These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1703692)

  • 1. Structural relationship between HLA-A2-restricted and anti-A2 allospecific T-cell recognition: analysis by mutation of the codons for polymorphic and conserved residues.
    Lombardi G; Matsui M; Moots R; Aichinger G; Sidhu S; Batchelor R; McMichael AJ; Frelinger J; Lechler R
    Transplant Proc; 1991 Feb; 23(1 Pt 1):446-8. PubMed ID: 1703692
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes.
    Mattson DH; Shimojo N; Cowan EP; Baskin JJ; Turner RV; Shvetsky BD; Coligan JE; Maloy WL; Biddison WE
    J Immunol; 1989 Aug; 143(4):1101-7. PubMed ID: 2473117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens.
    Bjorkman PJ; Saper MA; Samraoui B; Bennett WS; Strominger JL; Wiley DC
    Nature; 1987 Oct 8-14; 329(6139):512-8. PubMed ID: 2443855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2.
    Salter RD; Benjamin RJ; Wesley PK; Buxton SE; Garrett TP; Clayberger C; Krensky AM; Norment AM; Littman DR; Parham P
    Nature; 1990 May; 345(6270):41-6. PubMed ID: 2109837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2.
    Robbins PA; Lettice LA; Rota P; Santos-Aguado J; Rothbard J; McMichael AJ; Strominger JL
    J Immunol; 1989 Dec; 143(12):4098-103. PubMed ID: 2480387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.
    Ware CF; Krangel MS; Pious D; Burakoff SJ; Strominger JL
    J Immunol; 1983 Sep; 131(3):1312-7. PubMed ID: 6193184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1989 Mar; 142(6):2097-104. PubMed ID: 2466083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptides corresponding to the CD8 binding region of HLA class I block the differentiation of cytotoxic T lymphocyte precursors.
    Krensky AM; Lyu SC; Pouletty P; Benjamin R; Parham P; Clayberger C
    Transplant Proc; 1993 Feb; 25(1 Pt 1):483-4. PubMed ID: 8438388
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of a human CD8+ T lymphocyte neo-epitope created by a ras codon 12 mutation which is restricted by the HLA-A2 allele.
    Bergmann-Leitner ES; Kantor JA; Shupert WL; Schlom J; Abrams SI
    Cell Immunol; 1998 Aug; 187(2):103-16. PubMed ID: 9732698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan.
    Lin HJ; Cherng JM; Hung MS; Sayion Y; Lin JC
    J Biomed Sci; 2005 Dec; 12(6):925-36. PubMed ID: 16307312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T lymphocyte-defined epitope differences between HLA-A2.1 and HLA-A2.2 map to two distinct regions of the molecule.
    Hogan KT; Clayberger C; Le AX; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1988 Dec; 141(11):4005-11. PubMed ID: 2460555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition.
    Pandolfi F; Boyle LA; Trentin L; Kurnick JT; Isselbacher KJ; Gattoni-Celli S
    Cancer Res; 1991 Jun; 51(12):3164-70. PubMed ID: 1904004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1988 Oct; 141(7):2519-25. PubMed ID: 2459215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human allospecific cytolytic T lymphocyte lysis of a murine cell transfected with HLA-A2.
    Koller TD; Clayberger C; Maryanski JL; Krensky AM
    J Immunol; 1987 Apr; 138(7):2044-9. PubMed ID: 3549894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein.
    Butterfield LH; Koh A; Meng W; Vollmer CM; Ribas A; Dissette V; Lee E; Glaspy JA; McBride WH; Economou JS
    Cancer Res; 1999 Jul; 59(13):3134-42. PubMed ID: 10397256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes.
    Slingluff CL; Cox AL; Henderson RA; Hunt DF; Engelhard VH
    J Immunol; 1993 Apr; 150(7):2955-63. PubMed ID: 7681084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
    Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers.
    Wizel B; Houghten R; Church P; Tine JA; Lanar DE; Gordon DM; Ballou WR; Sette A; Hoffman SL
    J Immunol; 1995 Jul; 155(2):766-75. PubMed ID: 7541824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein.
    Engelhard VH; Lacy E; Ridge JP
    J Immunol; 1991 Feb; 146(4):1226-32. PubMed ID: 1704033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the molecular basis of HLA-A3 recognition by cytotoxic T cells using defined mutants of the HLA-A3 molecule.
    Jelachich ML; Cowan EP; Turner RV; Coligan JE; Biddison WE
    J Immunol; 1988 Aug; 141(4):1108-13. PubMed ID: 2456340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.